Everolimus (RAD001), a derivative of rapamycin, is commonly used as a drug for the inhibition of the mTOR pathway, affecting tumor cell division and angiogenesis.
Synonyms: 42-O-(2-Hydroxyethyl)rapamycin
Molecular Formula: C53H83NO14
Molecular Weight: 958.22
Linear Structural Formula: C53H83NO14
MDL Number: MFCD00929329
Purity: >=75.0% (qNMR)
Storage: -20C
Application: Everolimus may be used as a standard in the following clinical studies:
•Investigation of its glucose-dependent growth-inhibitory property in breast cancer cell lines.
•Evaluate its possible antiproliferative effects in human bronchial carcinoids in primary culture.